Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017246 | SCV005640897 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-16 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005017246 | SCV005919485 | likely benign | Polycystic kidney disease, adult type | 2024-04-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004739974 | SCV005353893 | uncertain significance | PKD1-related disorder | 2024-04-03 | no assertion criteria provided | clinical testing | The PKD1 c.3613G>C variant is predicted to result in the amino acid substitution p.Asp1205His. This variant was reported in an individual with a family history of polycystic kidney disease (Table 2, He et al 2018. PubMed ID: 30333007). This variant is reported in 0.089% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |